Tirofiban

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Tirofiban is a glycoprotein IIb/IIIa receptor blocker. The binding to the GPIIb-/IIIa-receptors is reversible

IndicationThis section has been translated automatically.

Unstable angina pectoris and non-Q-wave infarction

Dosage and method of useThis section has been translated automatically.

Initially 0.4 ug/kg/min over 30 minutes i.v., then 0.1 ug/kg/min over 48 hours

PreparationsThis section has been translated automatically.

Aggrastat®

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020